Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history

SA Bonini, M Premoli, S Tambaro, A Kumar… - Journal of …, 2018 - Elsevier
Ethnopharmacological relevance Cannabis sativa L.(C. sativa) is an annual dioecious plant,
which shares its origins with the inception of the first agricultural human societies in Asia …

The CB2 receptor and its role as a regulator of inflammation

C Turcotte, MR Blanchet, M Laviolette… - Cellular and Molecular …, 2016 - Springer
The CB 2 receptor is the peripheral receptor for cannabinoids. It is mainly expressed in
immune tissues, highlighting the possibility that the endocannabinoid system has an …

Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment

M Premoli, F Aria, SA Bonini, G Maccarinelli… - Life Sciences, 2019 - Elsevier
The pharmacological research on the Cannabis sativa-derived compounds has never
terminated. Among the phytocannabinoids without psychotropic effects, the prevalent one in …

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites

C Turcotte, F Chouinard, JS Lefebvre… - Journal of Leucocyte …, 2015 - academic.oup.com
Arachidonoyl-glycerol (2-AG) and arachidonyl-ethanolamide (AEA) are endocannabinoids
that have been implicated in many physiologic disorders, including obesity, metabolic …

[HTML][HTML] Potential and limits of cannabinoids in Alzheimer's disease therapy

G Abate, D Uberti, S Tambaro - Biology, 2021 - mdpi.com
Simple Summary This review was aimed at exploring the potentiality of drugging the
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …

CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome

A Cox, N Golda, G Nadeau, JC Nickel… - Canadian …, 2016 - pmc.ncbi.nlm.nih.gov
The following guidelines were based on MEDLINE and PUBMED searches of English
language literature, in addition to consensus conference proceedings. Levels of evidence …

Cannabimimetic plants: are they new cannabinoidergic modulators?

A Kumar, M Premoli, F Aria, SA Bonini, G Maccarinelli… - Planta, 2019 - Springer
Abstract Main Conclusion Phytochemicals and secondary metabolites able to interact with
the endocannabinoid system (Cannabimimetics) have been recently described in a broad …

[HTML][HTML] The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

V Rakotoarivelo, TZ Mayer, M Simard, N Flamand… - Molecules, 2024 - mdpi.com
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis
has been used for several millennia to treat inflammatory disorders such as rheumatism or …

[HTML][HTML] Broaden horizons: the advancement of interstitial cystitis/bladder pain syndrome

J Li, X Yi, J Ai - International Journal of Molecular Sciences, 2022 - mdpi.com
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating disease that induces
mental stress, lower urinary symptoms, and pelvic pain, therefore resulting in a decline in …

Animal modelling of interstitial cystitis/bladder pain syndrome

L Birder, KE Andersson - International neurourology journal, 2018 - pmc.ncbi.nlm.nih.gov
The etiology of interstitial cystitis/bladder pain syndrome (IC/BPS) remains elusive and may
involve multiple causes. To better understand its pathophysiology, many efforts have been …